Studies have shown that, during the development of DCM, myocardial AMPK phosphorylation is inhibited, and its activity is reduced, accompanied by reduced GLUT-4 membrane translocation [31], Fig. 8. This evidence concerns the gene SLC2A4 and familial dilated cardiomyopathy.